Sabih Beck, Roche
Sabih Beck, Oncology & Hematology Franchise Lead, Competitive Intelligence, Roche
Sabih Beck is the Global Oncology and Hematology Franchise lead at Roche’s headquarters in Switzerland. He majored in biochemistry and psychology from Lewis and Clark College (Portland, OR) and obtained his MBS from the Keck Graduate Institute (Claremont, CA).
In the current role Sabih supports oncology products’ marketing strategies by providing commercial recommendations with an external and future looking view on the market. Key responsibilities are planning and leading all strategic external research activities in competitive intelligence.
Prior to his current role, Sabih Beck was the Director of Integrated Insights at Novartis Global Headquarters in Switzerland. Core accountabilities included competitive intelligence, market research, business analytics and forecasting in order to ensure a comprehensive external view and identification of key business drivers for the franchise, ensuring a competitive edge.
Sabih Beck has over 10 years of experience in the field of competitive intelligence leading and building the Global CI function and capabilities in both specialty and primary care franchises within Roche and Novartis. Prior to joining Roche and Novartis he worked in competitive intelligence consulting for various pharmaceutical and biotech companies conducting and planning primary CI efforts, training associates on competitive intelligence & counterintelligence and leading wargames.
Dr. Rachid BenHamza, Helsinn Healthcare S.A.
Dr. Rachid BenHamza, Director Product Management, Commercial Operations, Helsinn Healthcare S.A.
Dr. Rachid BenHamza is Head of Corporate Product Management & Competitive Intelligence, Commercial Operations, at Helsinn Healthcare Switzerland.
In his career Rachid BenHamza has the opportunity to develop a wide experience in the Pharmaceutical Industry covering basic research and teaching at the University of Geneva, manufacturing of APIs in a couple of Swiss chemical plants, international sales management, licensing and business development where he spent over 10 years working on a worldwide basis, to his current position where he manage with his coworkers commercial teams responsible for the preparation and launch of new drugs. His current responsibility covers also the maintenance of an active Intelligence in the markets and in the therapeutical areas of interest for the company.
Among his activities within several associations, Rachid BenHamza is currently a board member of the Swiss Healthcare Licensing Group (previously Swiss Pharma Licensing Group, www.swisshlg.com), an association of 150 Executives working in business development and licensing, he co-founded 12 years ago, with other colleagues in the Swiss Pharma industry. He acted as vice-president and then president of this association until 2012.
Daniel Cho, Philips PCMS
Daniel Cho, Head of Global Pricing and Competitive Portfolio Analytics, Philips PCMS
Daniel is current the head of Global Pricing and Competitive Portfolio Analytics for Philips PCMS a 2.5B Euro branch within the Philips Healthcare business. Daniel started his career as a Management Consultant under PriceWaterhouse Sydney, then move on to have multiple Sales and APAC Sales Development positions before landing into a Global product manager position in Germany. While as the product manager position, Daniel had created the most profitable product Intellivue X2 for the Patient Monitoring business based on his extended knowledge of customer insight which drive a strong differential value proposition for the customers and for Philips. Daniel then take on the role of heading both Market Intelligence as well as Global New Product Introduction. Within the role, Daniel had development a strong knowledge management platform within Philips PCMS which now just pasted the 9 year mark and serving more than 2,000 individuals on a daily basis.
Daniel most recently took on a Global Pricing role, which has direct impact on the top and bottom line of the business. Major contribution for his team is to have successfully reversed the global price erosion for the most recent 3 quarters of business across all businesses. This bought very strong bottom line improvement while business still grew strong at high single digit.
Daniel had a passion for Competitive Intelligence and had been contributing to the global CI network within Philips PCMS. Recently he also took the role to head that function and making sure that Philips sales team getting the most impactful and updated competitive information, and make available multiple tactical tools for sales people to win the next deal. This unique use of CI information on a daily and per deal level brought along strong growth in market share despite operating in a very competitive and price driven environment.
Overall Daniel is most known for his knowledge in topics of Market Intelligence, Competitive Intelligence, Knowledge Management, Pricing and Profitability Improvement, Visual Analytics, Innovation and Value Propositions. Daniel was a keynote speaker in various global conferences and working with large global organizations as panel member and advisor.
Jacob Falck Hansen, Ph.D., Novo Nordisk A/S
Jacob Falck Hansen, Ph.D., Vice President, Head of Competitive Intelligence, Novo Nordisk A/S
Jacob heads the unit in Novo Nordisk responsible for CI within Diabetes and Obesity. He has been with Novo Nordisk since 2007 and worked in various business development and strategic planning roles and before joining the competitive intelligence unit in 2011. Prior to joining Novo Nordisk, he worked at the University of Cambridge , UK, and the Danish Cancer Society, and he has a Ph.D. in Molecular Biology from University of Copenhagen.
Sara Panigone, Chiesi Farmaceutici
Sara Panigone, Head of Global Competitive Intelligence, Corporate Marketing, Chiesi Farmaceutici
Sara Panigone started working in Chiesi Farmaceutici headquarter in 2007 as Scientific Adviser in the Department of Scientific Affairs within Corporate Marketing with tasks spanning from scientific support to Corporate products to new licensing opportunities evaluation. In early 2009 she became Scientific Intelligence Adviser until, in January 2011, she assumed the role of Competitive Intelligence Manager within the CI Unit in Corporate Marketing. Since June 2016, the Competitive Intelligence Unit becomes Global Competitive Intelligence Department, headed by Sara. The Global Competitive Intelligence Department currently works in support to several Company functions, including Board of Directors, Marketing and R&D, through scenario and competitors analyses, war games and alerting systems.
She graduated in Medical Biotechnology in 2004 at the University of Milan; between 2004 and 2007 she obtained a Ph.D. in Biotechnology Applied to Medical Sciences at the University of Milan in collaboration with Stanford University, where she worked as visiting researcher for 18 months.
Dr. Pablo Prados, Sanofi
Dr. Pablo Prados, Senior Director, Integrated Care, Global Biologics Division, Sanofi
Pablo Prados is Senior Director, Integrated Care Center of Excellence, Global Divisions & Strategic Development, in Sanofi.
Prior to this position, he was head of the Global Product Patrimony Management function in Global Operations, and the Global Competitive Intelligence function in R&D.
Pablo has worked in Japan for over 10 years in the Pharmaceutical industry, holding positions in both R&D and Pharmaceutical Operations, such as Regulatory Affairs Manager with Schering AG, Strategic Planning Director with Nippon Roche, New Products & Opportunities Head with Aventis Japan, and Business Analysis Head with sanofi-aventis Japan, before moving to France in 2007.
Pablo was born in Madrid and is a French and Spanish citizen. Pablo holds PhDs in Pharmaceutical Sciences from the University of Tokyo and the University Complutense of Madrid, and he received his EMBA from Temple University, PA, US.
Alfred Reszka, MSD
Alfred Reszka, Executive Director and Head of Global Competitive Intelligence, MSD
Alfred (Al) Reszka is Executive Director and Head of Global Competitive Intelligence at MSD. Al and his team work with clients in Strategy, Marketing, R&D and Manufacturing across a variety of business functions requiring scientific, medical and business intelligence. The group functions as a strategic consultancy within Merck that leverages intelligence to impact strategy and the top and bottom lines. Roles and responsibilities include consulting in product and pipeline intelligence across all therapeutic areas, portfolio prioritization, strategic benchmarking and strategy development, product surveillance and defense, mature product strategies, emerging markets, licensing, business development, M&A and the Merck Library.
Al joined Merck in 1997, and prior to joining the Global Competitive Intelligence group in 2007, he was Senior Research Fellow in Bone Basic Research in R&D, where he led research that elucidated the mechanism of action of alendronate (FOSAMAX) and where he led drug discovery efforts for a variety of osteoporosis programs.
Al earned his Ph.D. in Cell Biology at the University of Illinois, Urbana-Champaign in 1992 and subsequently conducted postdoctoral research on MAP Kinase (ERK1/2) mediated signal transduction with Nobel Laureates, Edmund Fischer and Edwin Krebs at the University of Washington in Seattle.
Heresh Rezavandi, BSc. MSc. PhD., UCB Pharma
Heresh Rezavandi, BSc. MSc. PhD., Global Ecosystem Strategic Intelligence Lead, Foresight, UCB Pharma
Heresh is the Global Competitive Intelligence Lead for UCB, a biopharmaceutical company specialising in immunological and CNS disorders. Heresh has a PhD, MSc and BSc in the medical sciences. Heresh was trained by in competitive intelligence when working for consultancies that specialise in this practice. Afterwards, Heresh was invited by UCB to initially set up its R&D CI practice and shortly after led the Global Competitive Intelligence activities as well. Experience includes primary competitive intelligence, competitive intelligence for in-licensing and out-licensing of biopharmaceutical therapies, benchmarking, corporate strategy, analysis of emerging therapies and technologies and market analysis for the pharmaceutical and healthcare industries.
Alexandre-Nicolas Richard, Sanofi
Alexandre-Nicolas Richard, Corporate M&A, Strategy & Business Development, Sanofi
• work 5 years in Competitive Intelligence, first for the Generics division of Sanofi and then at global level (in charge of C.I. at Global Operations).
• held progressive management positions in Financial Controlling at Sanofi
• started his career with Procter & Gamble in Central Europe & Germany
• graduated from ESCP Europe and INSEAD Business Schools